Contact
Please use this form to send email to PR contact of this press release:
Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
TO:
Please use this form to send email to PR contact of this press release:
Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
TO: